Researchers using next-generation DNA sequencing have identified four specific genes whose mutations are linked to the development and progression of lethal stomach cancers. This could potentially enable doctors to offer targeted treatments that would spare many patients from unnecessarily aggressive procedures, according to a study presented at Digestive Disease Week (DDW) 2025.
This article was originally published on MedicalXpress.com